Evidence map›Paper›PMID 32176708›Full record

ArticlePloS one2020

Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.

Michael G Jobling, Steven T Poole, Fatima Rasulova-Lewis, Aisling O'Dowd, Annette L McVeigh, Amit Balakrishnan, Stephanie A Sincock, Michael G Prouty, Randall K Holmes, Stephen J Savarino

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Recent progress in enterotoxigenicInfection and immunity · 2025
    Review
  2. Article
  3. Article
  4. Landmark Discoveries and Recent Advances in Type IV Pilus Research.Microbiology and molecular biology reviews : MMBR · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Michael G JoblingDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, United States of America.
Steven T PooleHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.ORCID 0000-0002-8047-2651
Fatima Rasulova-LewisHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Aisling O'DowdHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Annette L McVeighHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Amit BalakrishnanHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Stephanie A SincockEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States of America.
Michael G ProutyEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States of America.
Randall K HolmesDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, United States of America.
Stephen J SavarinoEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation · USNaval Medical Research Command · USUniversity of Colorado Denver · US

Funding

GENETIC ANALYSIS OF CHOLERA TOXIN STRUCTURE AND FUNCTIONR01AI031940 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, RANDALL K · 1992 to 2011
$5.9M
Development of an Adhesin-Toxoid Chimera Vaccine for Enterotoxigenic E. coliU01AI070638 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SAVARINO, STEPHEN J · 2006 to 2010
$4.3M
NIAID NIH HHS R01 AI031940NIAID NIH HHS U01 AI070638
6 · The paper itself

Abstract

Surface-expressed colonization factors and their subunits are promising candidates for inclusion into a multivalent vaccine targeting enterotoxigenic Escherichia coli (ETEC), a leading cause of acute bacterial diarrhea in developing regions. However, soluble antigens are often poorly immunogenic in the absence of an adjuvant. We show here that the serum immune response to CfaE, the adhesin of the ETEC colonization factor CFA/I, can be enhanced in BALB/c mice by immunization with a chimeric antigen containing CfaE and pentameric cholera toxin B subunit (CTB) of cholera toxin from Vibrio cholerae. We constructed this antigen by replacing the coding sequence for the A1 domain of the cholera toxin A subunit (CTA) with the sequence of donor strand complemented CfaE (dscCfaE) within the cholera toxin operon, resulting in a dscCfaE-CTA2 fusion. After expression, via non-covalent interactions between CTA2 and CTB, the fusion and CTB polypeptides assemble into a complex containing a single dscCfaE-CTA2 protein bound to pentameric CTB (dscCfaE-CTA2/CTB). This holotoxin-like chimera retained the GM1 ganglioside binding activity of CTB, as well as the ability of CfaE to mediate the agglutination of bovine red blood cells when adsorbed to polystyrene beads. When administered intranasally to mice, the presence of CTB in the chimera significantly increased the serum immune response to CfaE compared to dscCfaE alone, stimulating a response similar to that obtained with a matched admixture of dscCfaE and CTB. However, by the orogastric route, immunization with the chimera elicited a superior functional immune response compared to an equivalent admixture of dscCfaE and CTB, supporting further investigation of the chimera as an ETEC vaccine candidate.

Indexed as

Cholera ToxinEnterotoxigenic Escherichia coliEscherichia coli VaccinesFimbriae ProteinsRecombinant Fusion ProteinsAdhesins, BacterialAdjuvants, ImmunologicAnimalsFemaleImmunizationImmunogenicity, VaccineMiceMice, Inbred BALB CAdhesins, BacterialAdjuvants, ImmunologicCholera Toxincolonization factor antigensEscherichia coli VaccinesFimbriae ProteinsRecombinant Fusion Proteins

Identifiers

PMID32176708
PMCPMC7075575
OpenAlexW3010845770

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.